Showing results (351-360 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|January 10, 2015
Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic ImpactMieke J Aarts, Joachim G Aerts, Ben E van den Borne, et al.
Clinical Lung Cancer|January 10, 2015
Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairmentCorey J Langer, Vera Hirsh, Amy Ko, et al.
Clinical Lung Cancer|December 3, 2014
Chemoprevention and screening for lung cancer: changing our focus to former smokersGerald Clamon
Clinical Lung Cancer|December 31, 2014
Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized TrialsClaire L Vale, Sarah Burdett, David J Fisher, et al.
Clinical Lung Cancer|December 3, 2014
Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapyHongmei Wang, Zhongxing Liao, Yan Zhuang, et al.
Clinical Lung Cancer|December 3, 2014
Prospective assessment of pemetrexed or pemetrexed plus platinum in combination with gefitinib or erlotinib in patients with acquired resistance to gefitinib or erlotinib: a phase II exploratory and preliminary studyShaomin Yu, Bin Zhang, Chengcheng Xiang, et al.
Clinical Lung Cancer|December 3, 2014
Clinical likelihood of sporadic primary EGFR T790M mutation in EGFR-mutant lung cancerYoungjoo Lee, Geon Kook Lee, Jung-Ah Hwang, et al.
Clinical Lung Cancer|December 3, 2014
Long-term lung cancer survivors have permanently decreased quality of life after surgeryVille Rauma, Harri Sintonen, Jari V Räsänen, et al.
Clinical Lung Cancer|December 3, 2014
An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancerCornelius F Waller, Ihor Vynnychenko, Igor Bondarenko, et al.
Clinical Lung Cancer|January 15, 2020
Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network ApproachShawna T Chan, Dan Ruan, Narek Shaverdian, et al.
Pageof 234